✦ LIBER ✦

Interplay of p53 and DNA-repair protein XRCC4 in tumorigenesis, genomic stability and development

✍ Scribed by Gao, Yijie; Ferguson, David O.; Xie, Wei; Manis, John P.; Sekiguchi, JoAnn; Frank, Karen M.; Chaudhuri, Jayanta; Horner, James; DePinho, Ronald A.; Alt, Frederick W.

Book ID: 109769334
Publisher: Nature Publishing Group
Year: 2000
Tongue: English
Weight: 416 KB
Volume: 404
Category: Article
ISSN: 0028-0836
DOI: 10.1038/35009138

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Polymorphisms in DNA repair genes XPD an

Polymorphisms in DNA repair genes XPD and XRCC1 and p53 mutations in lung carcinomas of never-smokers

✍ Wei-Min Gao; Marjorie Romkes; Jill M. Siegfried; James D. Luketich; Phouthone Ke 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB

## Abstract The etiology of lung cancer in population with little or no tobacco exposure is not well understood. Individual genetic susceptibility factors have been suggested to contribute to lung cancer risk in this population. Mutations in the p53 tumor suppressor gene are implicated in the devel

Roles of RECQ helicases in recombination

Roles of RECQ helicases in recombination based DNA repair, genomic stability and aging

✍ Dharmendra Kumar Singh; Byungchan Ahn; Vilhelm A. Bohr 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 455 KB

Disruption of the p53–p53r2 DNA repair s

Disruption of the p53–p53r2 DNA repair system in ulcerative colitis contributes to colon tumorigenesis

✍ Tsutomu Yoshida; Shiori Haga; Yoshiko Numata; Kazuya Yamashita; Tetuo Mikami; Ta 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 663 KB

With ulcerative colitis (UC)-associated tumorigenesis, p53 gene alteration is considered to be a key event. To clarify whether the p53-checkpoint is operating in foci of inflammation and that its disruption is a feature of UC-associated neoplasms, the present immunohistochemical study was conducted.

p53 status correlates with the different

p53 status correlates with the differential expression of the DNA mismatch repair protein MSH2 in non-small cell lung carcinoma

✍ George Xinarianos; Triantafillos Liloglou; Wendy Prime; George Sourvinos; Andrea 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 855 KB

We examined the p53 status of 108 NSCLCs compared to the expression of MLH1 and MSH2 proteins. p53 overexpression was demonstrated by IHC in 64% of patients examined, whereas p53 mutations were detected in 43%. Twenty-two percent of mutations were located outside of the hot-spot (exons 5-8) area. p5